Purchases and Sales Made in Q3 2023 in Biomarin Pharmaceutical Inc (BMRN)
This table provides information about the institutional ownership of Biomarin Pharmaceutical Inc (BMRN) during Q3 2023. The information is specifically focused on institutions that hold shares of BIOMARIN PHARMACEUTICAL INC.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 13, 2023
Q3 2023
|
Ubs Asset Management Americas Inc
Chicago, IL |
SELL
|
- |
-101K- 11.75% |
$8.57M - $9.51M
|
756K
$50.4M
|
|
|
Nov 14, 2023
Q3 2023
|
Hhlr Advisors, Ltd.
Grand Cayman, E9 |
SELL
|
- |
-115K- 50.19% |
$9.77M - $10.9M
|
114K
$7.6M
|
|
|
Nov 14, 2023
Q3 2023
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
SELL
|
- |
-123K- 28.05% |
$10.4M - $11.6M
|
315K
$21M
|
|
|
Nov 15, 2023
Q3 2023
|
Morgan Stanley
New York, NY |
SELL
|
- |
-125K- 14.07% |
$10.6M - $11.8M
|
762K
$50.7M
|
|
|
Nov 14, 2023
Q3 2023
|
Dodge & Cox
San Francisco, CA |
SELL
|
- |
-137K- 0.96% |
$11.6M - $12.9M
|
14.2M
$943M
|
|
|
Nov 14, 2023
Q3 2023
|
Avoro Capital Advisors LLC
New York, NY |
SELL
|
- |
-150K- 3.75% |
$12.8M - $14.2M
|
3.85M
$257M
|
|
|
Nov 14, 2023
Q3 2023
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
SELL
|
- |
-151K- 20.59% |
$12.8M - $14.3M
|
582K
$38.8M
|
|
|
Nov 14, 2023
Q3 2023
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
SELL
|
- |
-177K- 23.54% |
$15M - $16.7M
|
574K
$38.2M
|
|
|
Nov 21, 2023
Q3 2023
|
Braun Stacey Associates Inc
|
SELL
|
- |
-178K- 94.8% |
$15.1M - $16.8M
|
9.75K
$650K
|
|
|
Nov 14, 2023
Q3 2023
|
Man Group PLC
London, X0 |
SELL
|
- |
-186K- 66.57% |
$15.8M - $17.6M
|
93.4K
$6.22M
|
|
|
Nov 06, 2023
Q3 2023
|
Assenagon Asset Management S.A.
|
SELL
|
- |
-186K- 64.36% |
$15.8M - $17.6M
|
103K
$6.87M
|
|
|
Nov 14, 2023
Q3 2023
|
Nippon Life Global Investors Americas, Inc.
|
SELL
|
- |
-215K- 87.03% |
$18.3M - $20.3M
|
32.1K
$2.14M
|
|
|
Nov 13, 2023
Q3 2023
|
Franklin Resources Inc
San Mateo, CA |
SELL
|
- |
-270K- 32.29% |
$23M - $25.5M
|
566K
$37.7M
|
|
|
Nov 14, 2023
Q3 2023
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-341K- 70.66% |
$29M - $32.2M
|
142K
$9.43M
|
|
|
Nov 14, 2023
Q3 2023
|
Rockefeller Capital Management L.P.
New York, NY |
SELL
|
- |
-373K- 67.48% |
$31.7M - $35.2M
|
180K
$12M
|
|
|
Nov 14, 2023
Q3 2023
|
D. E. Shaw & Co., Inc.
New York, NY |
SELL
|
- |
-386K- 42.39% |
$32.8M - $36.4M
|
524K
$34.9M
|
|
|
Nov 13, 2023
Q3 2023
|
Qube Research & Technologies LTD
London, X0 |
SELL
|
- |
-408K- 83.3% |
$34.7M - $38.5M
|
81.7K
$5.44M
|
|
|
Nov 14, 2023
Q3 2023
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-455K- 31.73% |
$38.7M - $43M
|
980K
$65.3M
|
|
|
Nov 13, 2023
Q3 2023
|
Invesco Ltd.
Atlanta, GA |
SELL
|
- |
-536K- 54.42% |
$45.6M - $50.6M
|
449K
$29.9M
|
|
|
Nov 09, 2023
Q3 2023
|
Deutsche Bank Ag\
Frankfurt Am Main, 2M |
SELL
|
- |
-596K- 29.89% |
$50.7M - $56.3M
|
1.4M
$93.2M
|
|
|
Nov 13, 2023
Q3 2023
|
Capital Research Global Investors
Los Angeles, CA |
SELL
|
- |
-738K- 10.92% |
$62.8M - $69.7M
|
6.02M
$401M
|
|
|
Nov 13, 2023
Q3 2023
|
Carmignac Gestion
Paris, I0 |
SELL
|
- |
-1.08M- 99.99% |
$92M - $102M
|
100
$6.66K
|
|
|
Nov 13, 2023
Q3 2023
|
Norges Bank
Oslo, Q8 |
SELL
|
- |
-2.6MClosed |
$221M - $245M
|
0
$0
|